Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis

MLA

Laurent Misery, et al. “Oral Cyclosporin in Psoriasis: A Systematic Review on Treatment Modalities, Risk of Kidney Toxicity and Evidence for Use in Non-Plaque Psoriasis.” Journal of the European Academy of Dermatology and Venereology, vol. 25, Mar. 2011, pp. 19–27. EBSCOhost, https://doi.org/10.1111/j.1468-3083.2011.03992.x.

APA

Laurent Misery, Bernard Cribier, Henri Montaudié, Pascal Joly, Hervé Bachelez, M.-A. Richard, J.-P. Ortonne, M. Le Maître, Carle Paul, Selim Aractingi, F. Aubin, Aude Maza, Adeline Gallini, Denis Jullien, & Emilie Sbidian. (2011). Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. Journal of the European Academy of Dermatology and Venereology, 25, 19–27. https://doi.org/10.1111/j.1468-3083.2011.03992.x

Chicago

Laurent Misery, Bernard Cribier, Henri Montaudié, Pascal Joly, Hervé Bachelez, M.-A. Richard, J.-P. Ortonne, et al. 2011. “Oral Cyclosporin in Psoriasis: A Systematic Review on Treatment Modalities, Risk of Kidney Toxicity and Evidence for Use in Non-Plaque Psoriasis.” Journal of the European Academy of Dermatology and Venereology 25 (March): 19–27. doi:10.1111/j.1468-3083.2011.03992.x.